Status:
UNKNOWN
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
Lead Sponsor:
Unity Health Toronto
Collaborating Sponsors:
Alere, Inc.
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the changes in B-type Natriuretic Peptide (BNP) and amino-terminal fragment of proBNP (NT-proBNP) in outpatients managed in the heart failure (HF) clinic initia...
Detailed Description
Both natriuretic peptides (NP), namely B-type NP (BNP) and amino-terminal fragment of proBNP (NT-proBNP), have an established role in the management of patients with heart failure (HF).\[1\] However, ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Out Patient Protocol - Patients with chronic heart failure being followed in the heart failure clinic eligible to switch angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) to ARNI (Entresto).
- In Patient Protocol - Patients admitted due to acute decompensated heart failure
Exclusion
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04107220
Start Date
June 1 2016
End Date
June 1 2020
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael's Hospital
Toronto, Ontario, Canada, M5B1W8